Matinas Biopharma Holdings, Inc. (MTNB) vs Oragenics, Inc. (OGEN)

Matinas Biopharma Holdings, Inc. and Oragenics, Inc. are both Biotechnology companies. Matinas Biopharma Holdings, Inc. and Oragenics, Inc. are of similar size ($2.4M and $2.3M). Matinas Biopharma Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Oragenics, Inc. trades at 0.4×. Matinas Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 2,139.4% against −75.1%. Across the 15 metrics below, Oragenics, Inc. leads on 8 and Matinas Biopharma Holdings, Inc. on 7.

Valuation

Metric MTNB OGEN Biotechnology median
P/E n/m 0.44 7.88
P/S 0.24 17.54 11.47
P/B 0.57 0.59 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.16 0.74
EV/Sales 0.05 (13.16) 10.73
Earnings yield (731.25%) 228.10% (28.84%)
Free cash flow yield (595.22%) (469.27%) (23.03%)

Profitability

Metric MTNB OGEN Biotechnology median
Gross margin 0.00% 19.89% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (154.28%) (1,307.07%) (57.72%)
Return on assets (98.53%) (264.23%) (49.22%)
Return on invested capital (419.27%) 0.00% 0.00%

Growth

Metric MTNB OGEN Biotechnology median
Revenue growth (TTM) 2,139.41% (75.08%) 5.64%
EPS growth (last fiscal year) 59.84% 90.51% —
Revenue growth, 5-year CAGR 55.69% (50.98%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MTNB OGEN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.85 3.01 4.73
Net debt to EBITDA 0.62 0.98 0.96

Dividend

Metric MTNB OGEN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MTNB OGEN Biotechnology median
Market cap 2.41m 2.27m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack